Articles | Volume 11, issue 6
https://doi.org/10.5194/jbji-11-667-2026
© Author(s) 2026. This work is distributed under the Creative Commons Attribution 4.0 License.
Direct healthcare burden and costs of operatively managed prosthetic joint infection in a public hospital setting
Cited articles
Alt, V., Szymski, D., Rupp, M., Fontalis, A., Vaznaisiene, D., Marais, L. C., Wagner, C., and Walte, N.: The health-economic burden of hip and knee periprosthetic joint infections in Europe: A comprehensive analysis following primary arthroplasty, Bone Jt. Open, 6, 298–311, https://doi.org/10.1302/2633-1462.63.BJO-2024-0225.R1, 2025.
Bowers, F.: Waiting lists increased by 86,300 patients in 2025, new figures show, https://www.rte.ie/news/health/2026/0112/1552566-hospital-waiting-lists/ (last access: 29 August 2026), 2026.
Chapman, A. L. N., Dixon, S., Andrews, D., Lillie, P. J., Bazaz, R., and Patchett, J. D.: Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective, J. Antimicrob. Chemother., 64, 1316–1324, https://doi.org/10.1093/jac/dkp343, 2009.
Clausen, N., Pomeroy, E., Rowan, F., McKenna, P., and Cleary, M.: The burden of care in hip and knee prosthetic joint infections (PJI) in a regional unit, Ir. J. Med. Sci., 195, 1397–1403, https://doi.org/10.1007/s11845-026-04299-x, 2026.
González-Ramallo, V. J., Mirón-Rubio, M., Mujal, A., Estrada, O., Forné, C., Aragón, B., and Rivera, A. J.: Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain, Int. J. Antimicrob. Agents, 50, 114–118, https://doi.org/10.1016/j.ijantimicag.2017.02.017, 2017.